Craft

Immune Regulation

Total Funding

$52.4 M

Immune Regulation Summary

Company Summary

Overview
Immune Regulation is a clinical-stage biotech company providing technologies for resetting the immune system and developing therapies for inflammatory and immunological diseases. Its drug immune-resetting therapies reset the immune system from a pro-inflammatory to a regulatory state to induce long-term disease remission in patients with allergic and immune-mediated diseases.
Type
Private
Status
Active
Founded
2011
HQ
Great Shelford, GB | view all locations
Website
https://revolobio.com/
Cybersecurity rating
Sectors

Key People

  • Roly Foulkes

    Roly Foulkes, Chief Scientific Officer

  • Jonathan Rigby

    Jonathan Rigby, Group Chief Executive Officer and Director

  • Jonathan Gold

    Jonathan Gold, Chief Financial Officer

  • Jones W Bryan, Chief Business Officer

LocationsView all

1 location detected

  • Great Shelford, England HQ

    United Kingdom

    Windsor House, Station Court, Station Rd

Footer menu